| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $183.6M | +13.0% |
| R&D Expense | $2.0M | +0.0% |
| SG&A Expense | $58.8M | +1.8% |
| Operating Income | $10.5M | +143.7% |
| Pre-tax Income | $16.8M | +103.8% |
| Income Tax | -$9.2M | -8045.7% |
| Net Income | $23.7M | +260.2% |
| EPS (Basic) | $9.17 | +252.7% |
| EPS (Diluted) | $8.65 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.7M | +41.9% |
| Accounts Receivable | $40.5M | +28.5% |
| Inventory | $39.0M | -4.8% |
| Current Assets | $121.9M | +15.5% |
| Total Assets | $181.2M | +18.6% |
| Current Liabilities | $28.5M | +12.2% |
| Long-term Debt | $5.3M | -12.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $22.2M | +74.3% |
| Capital Expenditures | $1.2M | -8.3% |
| Investing Cash Flow | -$6.3M | -1413.8% |
| Financing Cash Flow | -$5.3M | -24.2% |
| Free Cash Flow | $21.0M | +83.7% |
| +239.2% |
| Total Liabilities |
| $38.1M |
| +3.8% |
| Stockholders' Equity | $126.2M | +27.7% |